Developing Eco-friendly Inhaled Anesthetics | Expanesthetics

Good for patients.
Good for the planet.

Imagine the next generation of inhaled anesthetics:
fewer side effects, smaller climate impact.

A win for patients, and the planet.

Join over 100 of your colleagues working to make that dream a reality.

Learn more

The discovery

For decades, inhaled anesthetic development was stagnant. Finally, a discovery revealed a path to new agents.

Our traction

We've pioneered a platform for developing new inhaled agents (with encouraging results so far).

What's next?

Next, it's time to screen more candidates in our pipeline for a clinical and climate advantage.

You can be part of it

Register to learn more about how you can be part of our exciting innovation.

By submitting your contact information, you agree for our team to contact you by email, text, and phone. (We will never share or sell your information.)

"I joined the Expanesthetics team as a shareholder because I see the potential for the technology to create incredibly positive change not only for my practice, but for the practice of anesthesia around the world."

Chauncey T. Jones, MD

Anesthesiologist and Business Owner, Houston, TX

Learn more

This is not an offer to sell or a solicitation of any offer to buy any securities. Offers are made only by prospectus or other offering materials. Expanesthetics cannot provide financial or tax advice; please check with your licensed financial and tax advisors before making an investment. Only prospective investors who have been invited to review such materials and meet the suitability standards required by law are eligible to invest. This prospectus includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Expanesthetics’ management and are subject to significant risks and uncertainties. There can be no guarantees. These statements are made as of the date of this communication and Expanesthetics assumes no obligation to provide updates. All product names, trademarks and registered trademarks are property of their respective owners. All company, product and service names used in this publication are for identification purposes only. Use of these names, trademarks and brands does not imply endorsement. Robert Brosnan is identified as Professor at UC Davis for identification purposes only and does not imply that the Regents of the University of California endorses or approves of this publication or any of the products, services or opinions of Expanesthetics.